A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States

被引:3
作者
Crocco, Elizabeth [1 ,2 ]
Curiel-Cid, Rosie E. [1 ,2 ]
Kitaigorodsky, Marcela [1 ]
Gonzalez-Jimenez, Christian J. [1 ]
Zheng, Diane [1 ]
Duara, Ranjan [2 ,3 ]
Loewenstein, David A. [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Ctr Cognit Neurosci & Aging, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
[2] 1Florida Alzheimers Dis Res Ctr, Miami, FL USA
[3] Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Memory Disorders, Miami, FL USA
关键词
Amyloid; biomarkers; cognitive screening; intrusion errors; mild cognitive impairment; neuroimaging; preclinical Alzheimer's disease; semantic interference; structural MRI; MILD COGNITIVE IMPAIRMENT; PROACTIVE SEMANTIC INTERFERENCE; ADAS-COG; DEMENTIA; RESPONSIVENESS; VALIDATION; GUIDELINES; RECOVERY; REGIONS; MEMORY;
D O I
10.3233/JAD-200790
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) is an increasingly utilized cognitive stress test designed to identify early cognitive changes associated with incipient neurodegenerative disease. Objective: To examine previously derived cut-points for cognitively unimpaired older adults that were suggestive of performance impairment on multiple subscales of the LAS SI-L. These cut-points were applied to a new sample of older adults who were cognitive healthy controls (HC: n= 26) and those on the Alzheimer's disease (AD) continuum from early stage mild cognitive impairment (EMCI: n= 28), late stage MCI (LMCI: n= 18) to mild AD (AD: n= 27). Methods: All participants were administered the LAS SI-L. All cognitively impaired participants were PET amyloid positive which likely reflects underlying AD neuropathology, while cognitively normal counterparts were deemed to have amyloid negative scans. Results: There was a monotonic relationship between the number of deficits on LAS SI-L subscales and independent classification of study groups with greater severity of cognitive impairment. Importantly, taken together, impairment on maximum learning ability and measures of proactive semantic interference (both reflected by cued recall and intrusion errors) correctly classified 74.1% of EMCI, 94.4% of LMCI, and 96.3% of AD. Only 7.7% of HC were incorrectly classified as having impairments. Conclusion: A modest number of LASSI-L subscales taking approximately 8 minutes to administer, had excellent discriminative ability using established cut-offs among individuals with presumptive stages of AD. This has potential implications for both clinical practice and clinical research settings targeting AD during early prodromal stages.
引用
收藏
页码:789 / 799
页数:11
相关论文
共 50 条
[31]   Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET [J].
Lopez-de-Eguileta, Alicia ;
Lage, Carmen ;
Lopez-Garcia, Sara ;
Pozueta, Ana ;
Garcia-Martinez, Maria ;
Kazimierczak, Martha ;
Bravo, Maria ;
de Arcocha-Torres, Maria ;
Banzo, Ignacio ;
Jimenez-Bonilla, Julio ;
Cervero, Andrea ;
Goikoetxea, Alexander ;
Rodriguez-Rodriguez, Eloy ;
Sanchez-Juan, Pascual ;
Casado, Alfonso .
PLOS ONE, 2020, 15 (09)
[32]   CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One [J].
Cretin, Benjamin ;
Bousiges, Olivier ;
Hautecloque, Geoffroy ;
Philippi, Nathalie ;
Blanc, Frederic ;
Dibitonto, Laure ;
Martin-Hunyadi, Catherine ;
Sellal, Francois .
FRONTIERS IN NEUROLOGY, 2021, 12
[33]   Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease [J].
Vannini, Patrizia ;
Arnariglio, Rebecca ;
Hanseeuw, Bernard ;
Johnson, Keith A. ;
McLaren, Donald G. ;
Chhatwal, Jasmeer ;
Pascual-Leone, Alvaro ;
Rentz, Dorene ;
Sperling, Reisa A. .
NEUROPSYCHOLOGIA, 2017, 99 :343-349
[34]   Disease Tracking Markers for Alzheimer's Disease at the Prodromal (MCI) Stage [J].
Drago, Valeria ;
Babiloni, Claudio ;
Bartres-Faz, David ;
Caroli, Anna ;
Bosch, Beatriz ;
Hensch, Tilman ;
Didic, Mira ;
Klafki, Hans-Wolfgang ;
Pievani, Michela ;
Jovicich, Jorge ;
Venturi, Luca ;
Spitzer, Philipp ;
Vecchio, Fabrizio ;
Schoenknecht, Peter ;
Wiltfang, Jans ;
Redolfi, Alberto ;
Forloni, Gianluigi ;
Blin, Olivier ;
Irving, Elaine ;
Davis, Ceri ;
Hardemark, Hans-goran ;
Frisoni, Giovanni B. .
JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 :159-199
[35]   Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease [J].
Parnetti, Lucilla ;
Chiasserini, Davide .
BIOMARKERS IN MEDICINE, 2011, 5 (04) :479-484
[36]   Amyloid imaging in prodromal Alzheimer's disease [J].
Rik Ossenkoppele ;
Bart NM van Berckel ;
Niels D Prins .
Alzheimer's Research & Therapy, 3
[37]   Amyloid imaging in prodromal Alzheimer's disease [J].
Ossenkoppele, Rik ;
van Berckel, Bart N. M. ;
Prins, Niels D. .
ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (05)
[38]   Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity [J].
Horvath, Andras ;
Szucs, Anna ;
Barcs, Gabor ;
Kamondi, Anita .
JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (03) :1175-1183
[39]   Age at onset reveals different functional connectivity abnormalities in prodromal Alzheimer's disease [J].
Pini, Lorenzo ;
Geroldi, Cristina ;
Galluzzi, Samantha ;
Baruzzi, Roberta ;
Bertocchi, Monica ;
Chito, Eugenia ;
Orini, Stefania ;
Romano, Melissa ;
Cotelli, Maria ;
Rosini, Sandra ;
Magnaldi, Silvia ;
Morassi, Mauro ;
Cobelli, Milena ;
Bonvicini, Cristian ;
Archetti, Silvana ;
Zanetti, Orazio ;
Frisoni, Giovanni B. ;
Pievani, Michela .
BRAIN IMAGING AND BEHAVIOR, 2020, 14 (06) :2594-2605
[40]   Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease [J].
Monge-Garcia, Sonia ;
Garcia-Ayllon, Maria-Salud ;
Sanchez-Paya, Jose ;
Gasparini-Berenguer, Ruth ;
Cortes-Gomez, Maria-Angeles ;
Saez-Valero, Javier ;
Monge-Argiles, Jose-Antonio .
FRONTIERS IN NEUROLOGY, 2023, 14